Access to medicines at risk as Brexit clock ticks
Many issues yet to be resolved before there can be free movement between UK and EU
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
London
TIME is running short for a Brexit agreement that will allow the free movement of medicines through the UK and the rest of the European Union.
A myriad of issues, including guidance on transferring product registration and drug testing in the region, are yet to be resolved, Alan Morrison, vice-president of regulatory affairs international for Merck & Co, said in an interview in London.
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Why where you park your joint venture matters: Lessons from a US$689 million shareholder dispute
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Singaporeans can now buy record amount of yen per Singdollar
